Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Market Closed - Euronext Paris 11:55:00 2026-08-17 EDT			5-day change	1st Jan Change
0.7260 ^EUR	+0.83%		+0.55%	-24.38%

06-29	Transgene SA - Special Call
06-25	Oddo BHF Stays Positive on Transgene

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

0ce04b9be8a812bade01e9277e.OTyyvKpbinc8OgD781avVKT0Br2lkFEbb3moa-vcsu0.flfw_cB2-QZVeVqOpROebZejTMT26Rp9GBjtWLSUhYRxftDTmDnPNFIMWQ~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
25-10-13	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
25-09-18	Transgene: analysts reiterate their recommendations after results
25-09-17	The day the Fed resumed its rate cuts
24-11-06	Transgene: Invest Securities remains Buy
24-10-15	Transgene: Invest Securities confirms its Buy recommendation
24-09-26	Transgene: Invest Securities confirms its opinion
23-06-06	Transgene: Invest Securities confirms its Buy rating
23-06-05	Transgene: Invest Securities reiterates its recommendation
23-03-22	Transgene: Invest Securities reduces its target
23-01-10	Transgene: Invest Securities confirms its Buy rating

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+52.78%
	WUXI APPTEC CO., LTD.					+14.63%
	ARGENX SE			-	-	+45.47%
	INSMED INCORPORATED					+61.67%
	WUXI BIOLOGICS (CAYMAN) INC.					+5.3%
	BIONTECH SE					+29.48%
	PHARMAESSENTIA CORPORATION					-12.52%
	GENMAB A/S					+18.92%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+9.52%
	EXELIXIS, INC.					+3.31%
	Average					+22.86%
	Weighted average by Cap.					+24.41%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7260EUR

Average target price

1.100EUR

Spread / Average Target

+51.52%

High Price Target

1.100EUR

Spread / Highest target

+51.52%

Low Price Target

1.100EUR

Spread / Lowest Target

+51.52%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7260EUR

Average target price

1.100EUR

Spread / Average Target

+51.52%

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Stock Market
Stocks
TNG Stock
Consensus Transgene

The best tools reserved for subscribers to boost the performance of your investments!